vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与REPUBLIC BANCORP INC（RBCAA）财务数据对比。点击上方公司名可切换其他公司
REPUBLIC BANCORP INC的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.2倍（$94.3M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 5.3%），REPUBLIC BANCORP INC自由现金流更多（$161.1M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -11.5%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
肯塔基州共和银行是美国的一家区域性银行控股企业，提供零售及商业银行全品类服务，涵盖个人存贷款、企业融资、按揭产品及财富管理解决方案，主要服务肯塔基州及周边州的个人消费者和中小企业客户。
PBYI vs RBCAA — 直观对比
营收规模更大
RBCAA
是对方的1.2倍
$75.5M
营收增速更快
PBYI
高出22.4%
5.3%
自由现金流更多
RBCAA
多$146.7M
$14.4M
两年增速更快
PBYI
近两年复合增速
-11.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $94.3M |
| 净利润 | — | $22.8M |
| 毛利率 | 69.3% | — |
| 营业利润率 | 22.7% | 29.3% |
| 净利率 | — | 24.2% |
| 营收同比 | 27.7% | 5.3% |
| 净利润同比 | — | 20.0% |
| 每股收益（稀释后） | $0.26 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYIRBCAA
| Q4 25 | $75.5M | $94.3M | ||
| Q3 25 | $54.5M | $93.5M | ||
| Q2 25 | $52.4M | $93.8M | ||
| Q1 25 | $46.0M | $135.8M | ||
| Q4 24 | $59.1M | $89.5M | ||
| Q3 24 | $80.5M | $88.1M | ||
| Q2 24 | $47.1M | $86.9M | ||
| Q1 24 | $43.8M | $120.3M |
净利润PBYIRBCAA
| Q4 25 | — | $22.8M | ||
| Q3 25 | $8.8M | $29.7M | ||
| Q2 25 | $5.9M | $31.5M | ||
| Q1 25 | $3.0M | $47.3M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | $20.3M | $26.5M | ||
| Q2 24 | $-4.5M | $25.2M | ||
| Q1 24 | $-4.8M | $30.6M |
毛利率PBYIRBCAA
| Q4 25 | 69.3% | — | ||
| Q3 25 | 77.7% | — | ||
| Q2 25 | 76.5% | — | ||
| Q1 25 | 77.1% | — | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | — | ||
| Q2 24 | 77.4% | — | ||
| Q1 24 | 75.5% | — |
营业利润率PBYIRBCAA
| Q4 25 | 22.7% | 29.3% | ||
| Q3 25 | 17.6% | 40.4% | ||
| Q2 25 | 12.7% | 43.0% | ||
| Q1 25 | 8.7% | 44.1% | ||
| Q4 24 | 22.6% | 25.8% | ||
| Q3 24 | 27.4% | 38.4% | ||
| Q2 24 | -4.6% | 37.0% | ||
| Q1 24 | -5.3% | 32.2% |
净利率PBYIRBCAA
| Q4 25 | — | 24.2% | ||
| Q3 25 | 16.2% | 31.8% | ||
| Q2 25 | 11.2% | 33.5% | ||
| Q1 25 | 6.5% | 34.8% | ||
| Q4 24 | — | 21.2% | ||
| Q3 24 | 25.2% | 30.1% | ||
| Q2 24 | -9.6% | 29.0% | ||
| Q1 24 | -11.0% | 25.4% |
每股收益（稀释后）PBYIRBCAA
| Q4 25 | $0.26 | — | ||
| Q3 25 | $0.17 | — | ||
| Q2 25 | $0.12 | — | ||
| Q1 25 | $0.06 | — | ||
| Q4 24 | $0.40 | — | ||
| Q3 24 | $0.41 | — | ||
| Q2 24 | $-0.09 | — | ||
| Q1 24 | $-0.10 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $220.0M |
| 总债务越低越好 | $22.7M | — |
| 股东权益账面价值 | $130.3M | $1.1B |
| 总资产 | $216.3M | $7.0B |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势，按日历期对齐
现金及短期投资PBYIRBCAA
| Q4 25 | $97.5M | $220.0M | ||
| Q3 25 | $94.4M | $484.2M | ||
| Q2 25 | $96.0M | $484.8M | ||
| Q1 25 | $93.2M | $793.0M | ||
| Q4 24 | $101.0M | $432.2M | ||
| Q3 24 | $96.7M | $530.9M | ||
| Q2 24 | $96.8M | $400.1M | ||
| Q1 24 | $107.2M | $546.4M |
总债务PBYIRBCAA
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
股东权益PBYIRBCAA
| Q4 25 | $130.3M | $1.1B | ||
| Q3 25 | $115.3M | $1.1B | ||
| Q2 25 | $104.7M | $1.1B | ||
| Q1 25 | $97.1M | $1.0B | ||
| Q4 24 | $92.1M | $992.0M | ||
| Q3 24 | $71.1M | $979.7M | ||
| Q2 24 | $48.5M | $955.4M | ||
| Q1 24 | $51.0M | $935.6M |
总资产PBYIRBCAA
| Q4 25 | $216.3M | $7.0B | ||
| Q3 25 | $202.9M | $7.0B | ||
| Q2 25 | $194.9M | $7.0B | ||
| Q1 25 | $196.2M | $7.1B | ||
| Q4 24 | $213.3M | $6.8B | ||
| Q3 24 | $220.7M | $6.7B | ||
| Q2 24 | $205.0M | $6.6B | ||
| Q1 24 | $214.1M | $6.9B |
负债/权益比PBYIRBCAA
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $168.2M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $161.1M |
| 自由现金流率自由现金流/营收 | 19.1% | 170.9% |
| 资本支出强度资本支出/营收 | 0.0% | 7.5% |
| 现金转化率经营现金流/净利润 | — | 7.37× |
| 过去12个月自由现金流最近4个季度 | $41.7M | $288.6M |
8季度趋势，按日历期对齐
经营现金流PBYIRBCAA
| Q4 25 | $14.4M | $168.2M | ||
| Q3 25 | $9.7M | $33.3M | ||
| Q2 25 | $14.1M | $8.4M | ||
| Q1 25 | $3.6M | $93.2M | ||
| Q4 24 | $15.6M | $149.0M | ||
| Q3 24 | $11.0M | $51.3M | ||
| Q2 24 | $1.0M | $4.0M | ||
| Q1 24 | $11.2M | $71.2M |
自由现金流PBYIRBCAA
| Q4 25 | $14.4M | $161.1M | ||
| Q3 25 | $9.7M | $30.8M | ||
| Q2 25 | $14.1M | $5.2M | ||
| Q1 25 | $3.6M | $91.6M | ||
| Q4 24 | $15.6M | $143.2M | ||
| Q3 24 | $11.0M | $49.8M | ||
| Q2 24 | $1.0M | $2.7M | ||
| Q1 24 | — | $69.1M |
自由现金流率PBYIRBCAA
| Q4 25 | 19.1% | 170.9% | ||
| Q3 25 | 17.7% | 32.9% | ||
| Q2 25 | 26.8% | 5.5% | ||
| Q1 25 | 7.7% | 67.4% | ||
| Q4 24 | 26.4% | 160.0% | ||
| Q3 24 | 13.7% | 56.5% | ||
| Q2 24 | 2.1% | 3.1% | ||
| Q1 24 | — | 57.5% |
资本支出强度PBYIRBCAA
| Q4 25 | 0.0% | 7.5% | ||
| Q3 25 | 0.0% | 2.6% | ||
| Q2 25 | 0.0% | 3.5% | ||
| Q1 25 | 0.1% | 1.2% | ||
| Q4 24 | 0.0% | 6.5% | ||
| Q3 24 | 0.0% | 1.7% | ||
| Q2 24 | 0.0% | 1.5% | ||
| Q1 24 | 0.0% | 1.7% |
现金转化率PBYIRBCAA
| Q4 25 | — | 7.37× | ||
| Q3 25 | 1.10× | 1.12× | ||
| Q2 25 | 2.41× | 0.27× | ||
| Q1 25 | 1.21× | 1.97× | ||
| Q4 24 | — | 7.84× | ||
| Q3 24 | 0.54× | 1.93× | ||
| Q2 24 | — | 0.16× | ||
| Q1 24 | — | 2.33× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
